132 related articles for article (PubMed ID: 1832994)
1. Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque.
Matthews DC; Appelbaum FR; Eary JF; Hui TE; Fisher DR; Martin PJ; Durack LD; Nelp WB; Press OW; Badger CC
Blood; 1991 Oct; 78(7):1864-74. PubMed ID: 1832994
[TBL] [Abstract][Full Text] [Related]
2. Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody.
Matthews DC; Badger CC; Fisher DR; Hui TE; Nourigat C; Appelbaum FR; Martin PJ; Bernstein ID
Cancer Res; 1992 Mar; 52(5):1228-34. PubMed ID: 1531324
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate model.
Nemecek ER; Hamlin DK; Fisher DR; Krohn KA; Pagel JM; Appelbaum FR; Press OW; Matthews DC
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):787-94. PubMed ID: 15701869
[TBL] [Abstract][Full Text] [Related]
4. Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.
Matthews DC; Appelbaum FR; Eary JF; Fisher DR; Durack LD; Bush SA; Hui TE; Martin PJ; Mitchell D; Press OW
Blood; 1995 Feb; 85(4):1122-31. PubMed ID: 7849300
[TBL] [Abstract][Full Text] [Related]
5. Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry Among Hematologic Malignancies.
Matesan M; Fisher DR; Wong R; Gopal AK; Green DJ; Sandmaier BM; Bensinger W; Pagel JM; Orozco J; Press OW; Cassaday RD; Hutchinson E; Wanner M; Pal S; Thostenson C; Rajendran JG
J Nucl Med; 2020 Sep; 61(9):1300-1306. PubMed ID: 32169919
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I.
Badger CC; Davis J; Nourigat C; Wu ZM; Hui TE; Fisher DR; Shulman H; Appelbaum FR; Eary JF; Krohn KA
Cancer Res; 1991 Nov; 51(21):5921-8. PubMed ID: 1682038
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.
Matthews DC; Appelbaum FR; Eary JF; Fisher DR; Durack LD; Hui TE; Martin PJ; Mitchell D; Press OW; Storb R; Bernstein ID
Blood; 1999 Aug; 94(4):1237-47. PubMed ID: 10438711
[TBL] [Abstract][Full Text] [Related]
8. Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.
Pagel JM; Hedin N; Subbiah K; Meyer D; Mallet R; Axworthy D; Theodore LJ; Wilbur DS; Matthews DC; Press OW
Blood; 2003 Mar; 101(6):2340-8. PubMed ID: 12446461
[TBL] [Abstract][Full Text] [Related]
9. Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
Buchmann I; Bunjes D; Kotzerke J; Martin H; Glatting G; Seitz U; Rattat D; Buck A; Döhner H; Reske SN
Cancer Biother Radiopharm; 2002 Apr; 17(2):151-63. PubMed ID: 12030109
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive effects of (131)I-anti-CD45 antibody in unsensitized and donor antigen-presensitized H2-matched, minor antigen-mismatched murine transplant models.
Ruffner KL; Martin PJ; Hussell S; Nourigat C; Fisher DR; Bernstein ID; Matthews DC
Cancer Res; 2001 Jul; 61(13):5126-31. PubMed ID: 11431350
[TBL] [Abstract][Full Text] [Related]
11. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support.
Press OW; Eary JF; Appelbaum FR; Martin PJ; Badger CC; Nelp WB; Glenn S; Butchko G; Fisher D; Porter B
N Engl J Med; 1993 Oct; 329(17):1219-24. PubMed ID: 7692295
[TBL] [Abstract][Full Text] [Related]
12. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia.
Glatting G; Müller M; Koop B; Hohl K; Friesen C; Neumaier B; Berrie E; Bird P; Hale G; Blumstein NM; Waldmann H; Bunjes D; Reske SN
J Nucl Med; 2006 Aug; 47(8):1335-41. PubMed ID: 16883014
[TBL] [Abstract][Full Text] [Related]
14. α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After 211At-Radioimmunotherapy for Hematopoietic Cell Transplantation.
Frost SH; Miller BW; Bäck TA; Santos EB; Hamlin DK; Knoblaugh SE; Frayo SL; Kenoyer AL; Storb R; Press OW; Wilbur DS; Pagel JM; Sandmaier BM
J Nucl Med; 2015 Nov; 56(11):1766-73. PubMed ID: 26338894
[TBL] [Abstract][Full Text] [Related]
15. Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models.
Matthews DC; Martin PJ; Nourigat C; Appelbaum FR; Fisher DR; Bernstein ID
Blood; 1999 Jan; 93(2):737-45. PubMed ID: 9885237
[TBL] [Abstract][Full Text] [Related]
16. Antibody-targeted therapy for myeloid leukemia.
Appelbaum FR
Semin Hematol; 1999 Oct; 36(4 Suppl 6):2-8. PubMed ID: 10530710
[TBL] [Abstract][Full Text] [Related]
17. Modelling radioimmunotherapy with anti-CD45 antibody to obtain a more favourable biodistribution.
Kiraly F; Kletting P; Reske S; Glatting G
Nuklearmedizin; 2009; 48(3):113-9. PubMed ID: 19322499
[TBL] [Abstract][Full Text] [Related]
18. Use of iodine-131-labeled anti-immune response-associated monoclonal antibody as preparative regimen prior to bone marrow transplantation: initial dosimetry.
Appelbaum FR; Badger CC; Deeg HJ; Nelp WB; Storb R
NCI Monogr; 1987; (3):67-71. PubMed ID: 3547145
[TBL] [Abstract][Full Text] [Related]
19. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
20. Preclinical studies targeting normal and leukemic hematopoietic cells with Yttrium-90-labeled anti-CD45 antibody in vitro and in vivo in nude mice.
Vallera DA; Elson M; Brechbiel MW; Dusenbery KE; Burns LJ; Skubitz KM; Jaszcz WB; Ramsay NK; Panoskaltsis-Mortari A; Kuroki DW; Wagner JE; Kersey JH
Cancer Biother Radiopharm; 2003 Apr; 18(2):133-45. PubMed ID: 12804039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
